Correlation Between BC Bud and HLS Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BC Bud and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BC Bud and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The BC Bud and HLS Therapeutics, you can compare the effects of market volatilities on BC Bud and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BC Bud with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BC Bud and HLS Therapeutics.

Diversification Opportunities for BC Bud and HLS Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between BCBCF and HLS is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding The BC Bud and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and BC Bud is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The BC Bud are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of BC Bud i.e., BC Bud and HLS Therapeutics go up and down completely randomly.

Pair Corralation between BC Bud and HLS Therapeutics

Assuming the 90 days horizon The BC Bud is expected to under-perform the HLS Therapeutics. In addition to that, BC Bud is 3.51 times more volatile than HLS Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. HLS Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest  269.00  in HLS Therapeutics on December 27, 2024 and sell it today you would earn a total of  51.00  from holding HLS Therapeutics or generate 18.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy93.44%
ValuesDaily Returns

The BC Bud  vs.  HLS Therapeutics

 Performance 
       Timeline  
BC Bud 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days The BC Bud has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, BC Bud is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
HLS Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

BC Bud and HLS Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BC Bud and HLS Therapeutics

The main advantage of trading using opposite BC Bud and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BC Bud position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.
The idea behind The BC Bud and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.